The Role of HTLV-1 Clonality, Proviral Structure, and Genomic Integration Site in Adult T-cell Leukemia/lymphoma

Overview

Journal Blood

Publisher Elsevier

Specialty Hematology

Date 2014 Apr 17

PMID 24735963

Citations 76

Authors

Lucy B Cook

Anat Melamed

Heather Niederer

Mikel Valganon

Daniel Laydon

Letizia Foroni

Graham P Taylor

Masao Matsuoka

Charles R M Bangham

Affiliations

Soon will be listed here.

Abstract

Adult T-cell leukemia/lymphoma (ATL) occurs in ∼5% of human T-lymphotropic virus type 1 (HTLV-1)-infected individuals and is conventionally thought to be a monoclonal disease in which a single HTLV-1(+) T-cell clone progressively outcompetes others and undergoes malignant transformation. Here, using a sensitive high-throughput method, we quantified clonality in 197 ATL cases, identified genomic characteristics of the proviral integration sites in malignant and nonmalignant clones, and investigated the proviral features (genomic structure and 5' long terminal repeat methylation) that determine its capacity to express the HTLV-1 oncoprotein Tax. Of the dominant, presumed malignant clones, 91% contained a single provirus. The genomic characteristics of the integration sites in the ATL clones resembled those of the frequent low-abundance clones (present in both ATL cases and carriers) and not those of the intermediate-abundance clones observed in 24% of ATL cases, suggesting that oligoclonal proliferation per se does not cause malignant transformation. Gene ontology analysis revealed an association in 6% of cases between ATL and integration near host genes in 3 functional categories, including genes previously implicated in hematologic malignancies. In all cases of HTLV-1 infection, regardless of ATL, there was evidence of preferential survival of the provirus in vivo in acrocentric chromosomes (13, 14, 15, 21, and 22).

Citing Articles

Long-term kinetics of proviral load in HTLV-1 carriers: defining risk for the development of adult T-cell leukemia/lymphoma.

Jimbo K, Nojima M, Toriuchi K, Yamagishi M, Nakashima M, Yamano Y Biomark Res. 2025; 13(1):34.

PMID: 40012084 PMC: 11863581. DOI: 10.1186/s40364-025-00747-5.

A narrative review: exploring viral-induced malignancies through the lens of dysregulated cellular metabolism and glucose transporters.

Shahpar A, Hamidi Sofiani V, Nezhad N, Charostad M, Ghaderi R, Farsiu N BMC Cancer. 2024; 24(1):1329.

PMID: 39472817 PMC: 11520837. DOI: 10.1186/s12885-024-13013-y.

C G composition in transposon-derived genes is increased in FXD with perturbed immune system.

Suganuma T, Hassan H, Gogol M, Workman J NAR Mol Med. 2024; 1(4):ugae015.

PMID: 39465205 PMC: 11500580. DOI: 10.1093/narmme/ugae015.

High level of genomic divergence in orf-I p12 and hbz genes of HTLV-1 subtype-C in Central Australia.

Hirons A, Yurick D, Jansz N, Ellenberg P, Franchini G, Einsiedel L Retrovirology. 2024; 21(1):14.

PMID: 39014486 PMC: 11253349. DOI: 10.1186/s12977-024-00647-w.

Role of the CTCF Binding Site in Human T-Cell Leukemia Virus-1 Pathogenesis.

Joseph A, Cheng X, Harding J, Al-Saleem J, Green P, Veis D bioRxiv. 2024; .

PMID: 38853836 PMC: 11160593. DOI: 10.1101/2024.05.28.596170.

References

Shimoyama M . Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87). Br J Haematol. 1991; 79(3):428-37. DOI: 10.1111/j.1365-2141.1991.tb08051.x. View

MacNamara A, Rowan A, Hilburn S, Kadolsky U, Fujiwara H, Suemori K . HLA class I binding of HBZ determines outcome in HTLV-1 infection. PLoS Pathog. 2010; 6(9):e1001117. PMC: 2944806. DOI: 10.1371/journal.ppat.1001117. View

Cook L, Rowan A, Melamed A, Taylor G, Bangham C . HTLV-1-infected T cells contain a single integrated provirus in natural infection. Blood. 2012; 120(17):3488-90. PMC: 3482858. DOI: 10.1182/blood-2012-07-445593. View

Kwok S, Ehrlich G, Poiesz B, Kalish R, Sninsky J . Enzymatic amplification of HTLV-I viral sequences from peripheral blood mononuclear cells and infected tissues. Blood. 1988; 72(4):1117-23. View

Takeda S, Maeda M, Morikawa S, Taniguchi Y, Yasunaga J, Nosaka K . Genetic and epigenetic inactivation of tax gene in adult T-cell leukemia cells. Int J Cancer. 2004; 109(4):559-67. DOI: 10.1002/ijc.20007. View

Tsukasaki K, Tsushima H, Yamamura M, Hata T, Murata K, Maeda T . Integration patterns of HTLV-I provirus in relation to the clinical course of ATL: frequent clonal change at crisis from indolent disease. Blood. 1997; 89(3):948-56. View

Sadelain M, Papapetrou E, Bushman F . Safe harbours for the integration of new DNA in the human genome. Nat Rev Cancer. 2011; 12(1):51-8. DOI: 10.1038/nrc3179. View

Matsuoka M, Jeang K . Human T-cell leukemia virus type 1 (HTLV-1) and leukemic transformation: viral infectivity, Tax, HBZ and therapy. Oncogene. 2010; 30(12):1379-89. PMC: 3413891. DOI: 10.1038/onc.2010.537. View

Gillet N, Malani N, Melamed A, Gormley N, Carter R, Bentley D . The host genomic environment of the provirus determines the abundance of HTLV-1-infected T-cell clones. Blood. 2011; 117(11):3113-22. PMC: 3062313. DOI: 10.1182/blood-2010-10-312926. View

10.

Tamiya S, Matsuoka M, Etoh K, Watanabe T, Kamihira S, Yamaguchi K . Two types of defective human T-lymphotropic virus type I provirus in adult T-cell leukemia. Blood. 1996; 88(8):3065-73. View

11.

Demontis M, Hilburn S, Taylor G . Human T cell lymphotropic virus type 1 viral load variability and long-term trends in asymptomatic carriers and in patients with human T cell lymphotropic virus type 1-related diseases. AIDS Res Hum Retroviruses. 2012; 29(2):359-64. DOI: 10.1089/AID.2012.0132. View

12.

Sasaki D, Doi Y, Hasegawa H, Yanagihara K, Tsukasaki K, Iwanaga M . High human T cell leukemia virus type-1(HTLV-1) provirus load in patients with HTLV-1 carriers complicated with HTLV-1-unrelated disorders. Virol J. 2010; 7:81. PMC: 2876101. DOI: 10.1186/1743-422X-7-81. View

13.

Berry C, Gillet N, Melamed A, Gormley N, Bangham C, Bushman F . Estimating abundances of retroviral insertion sites from DNA fragment length data. Bioinformatics. 2012; 28(6):755-62. PMC: 3307109. DOI: 10.1093/bioinformatics/bts004. View

14.

Bangham C, Cook L, Melamed A . HTLV-1 clonality in adult T-cell leukaemia and non-malignant HTLV-1 infection. Semin Cancer Biol. 2013; 26:89-98. PMC: 4062949. DOI: 10.1016/j.semcancer.2013.11.003. View

15.

Vogelstein B, Papadopoulos N, Velculescu V, Zhou S, Diaz Jr L, Kinzler K . Cancer genome landscapes. Science. 2013; 339(6127):1546-58. PMC: 3749880. DOI: 10.1126/science.1235122. View

16.

Meekings K, Leipzig J, Bushman F, Taylor G, Bangham C . HTLV-1 integration into transcriptionally active genomic regions is associated with proviral expression and with HAM/TSP. PLoS Pathog. 2008; 4(3):e1000027. PMC: 2265437. DOI: 10.1371/journal.ppat.1000027. View

17.

Bangham C . CTL quality and the control of human retroviral infections. Eur J Immunol. 2009; 39(7):1700-12. DOI: 10.1002/eji.200939451. View

18.

Laydon D, Melamed A, Sim A, Gillet N, Sim K, Darko S . Quantification of HTLV-1 clonality and TCR diversity. PLoS Comput Biol. 2014; 10(6):e1003646. PMC: 4063693. DOI: 10.1371/journal.pcbi.1003646. View

19.

Melamed A, Laydon D, Gillet N, Tanaka Y, Taylor G, Bangham C . Genome-wide determinants of proviral targeting, clonal abundance and expression in natural HTLV-1 infection. PLoS Pathog. 2013; 9(3):e1003271. PMC: 3605240. DOI: 10.1371/journal.ppat.1003271. View

20.

Barski A, Cuddapah S, Cui K, Roh T, Schones D, Wang Z . High-resolution profiling of histone methylations in the human genome. Cell. 2007; 129(4):823-37. DOI: 10.1016/j.cell.2007.05.009. View